SPONSOR
Stemline Therapeutics, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Platinum-resistant Ovarian Cancer
Stemline Therapeutics, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Platinum-resistant Ovarian Cancer.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Stemline Therapeutics, Inc.
How many clinical trials has Stemline Therapeutics, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Stemline Therapeutics, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Platinum-resistant Ovarian Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Stemline Therapeutics, Inc. research focus on?
Stemline Therapeutics, Inc. clinical trials span Platinum-resistant Ovarian Cancer. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Stemline Therapeutics, Inc. clinical trial?
To participate in a Stemline Therapeutics, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Stemline Therapeutics, Inc. trials with current recruitment status updated daily.
Clinical Trials by Stemline Therapeutics, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology